| Melvin D Brown, PA-C | |
|
1648 Alameda Blvd Nw, Albuquerque, NM 87114-8807 | |
| (505) 944-7508 | |
| (505) 998-6927 |
| Full Name | Melvin D Brown |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 31 Years |
| Location | 1648 Alameda Blvd Nw, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053327783 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | PA2003-0007 (New Mexico) | Secondary |
| 363A00000X | Physician Assistant | PA2003-0007 (New Mexico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| National Sinus Institute Pllc | 9234284407 | 31 |
News Archive
Magnetic resonance tomography (MRT) images are an important diagnostic tool. The achievable contrast depends on how well the nuclear spins that form the basis of the imaging signals can be controlled. Mathematically, the properties of nuclear spins are described by special matrices.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, and Shire plc, the global specialty biopharmaceutical company, today announced a joint development and commercialization agreement for ACE-031 and other novel molecules targeting the activin receptor type IIB (ActRIIB) pathway. This pathway plays critical roles in regulating the growth of skeletal muscle.
During the opening session of the SNIS Annual Meeting, J Mocco, MD, MS, Assistant Professor of Neurosurgery at The University of Florida in Gainesville, FL, announced the IDE approval and initiation of THERAPY, an industry-sponsored randomized controlled trial designed to prove the clinical benefit of interventional treatment of acute ischemic stroke.
The presence of circulating tumor cells in the blood appears to have no relationship to survival in women who have just been diagnosed with inflammatory breast cancer, according to new research from Fox Chase Cancer Center.
Use of a common antibiotic may be undercutting its utility as a first-line defense against drug-resistant tuberculosis (TB). Fluoroquinolones are the most commonly prescribed class of antibiotics in the U.S. and are used to fight a number of different infections such as sinusitis and pneumonia. They are also an effective first line of defense against TB infections that show drug resistance. New research shows, however, that widespread general use of fluoroquinolones may be creating a strain of fluoroquinolone-resistant TB.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melvin D Brown, PA-C 1648 Alameda Blvd Nw, Albuquerque, NM 87114-8807 Ph: (505) 944-7508 | Melvin D Brown, PA-C 1648 Alameda Blvd Nw, Albuquerque, NM 87114-8807 Ph: (505) 944-7508 |
News Archive
Magnetic resonance tomography (MRT) images are an important diagnostic tool. The achievable contrast depends on how well the nuclear spins that form the basis of the imaging signals can be controlled. Mathematically, the properties of nuclear spins are described by special matrices.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, and Shire plc, the global specialty biopharmaceutical company, today announced a joint development and commercialization agreement for ACE-031 and other novel molecules targeting the activin receptor type IIB (ActRIIB) pathway. This pathway plays critical roles in regulating the growth of skeletal muscle.
During the opening session of the SNIS Annual Meeting, J Mocco, MD, MS, Assistant Professor of Neurosurgery at The University of Florida in Gainesville, FL, announced the IDE approval and initiation of THERAPY, an industry-sponsored randomized controlled trial designed to prove the clinical benefit of interventional treatment of acute ischemic stroke.
The presence of circulating tumor cells in the blood appears to have no relationship to survival in women who have just been diagnosed with inflammatory breast cancer, according to new research from Fox Chase Cancer Center.
Use of a common antibiotic may be undercutting its utility as a first-line defense against drug-resistant tuberculosis (TB). Fluoroquinolones are the most commonly prescribed class of antibiotics in the U.S. and are used to fight a number of different infections such as sinusitis and pneumonia. They are also an effective first line of defense against TB infections that show drug resistance. New research shows, however, that widespread general use of fluoroquinolones may be creating a strain of fluoroquinolone-resistant TB.
› Verified 2 days ago